Insights from 2023 ASCO® Annual Meeting

 

Insights from 2023 ASCO® Annual Meeting
N

ASCO® 2023 Insights: "A Phase 1b Trial Evaluating the Safety of Ribociclib, Tucatinib, & Trastuzumab for HER2+ mBC & Phase 2 Study of Preoperative Treatment With Ribociclib, Trastuzumab, Tucatinib +/- Fulvestrant vs. Docetaxel, Carboplatin, Trastuzumab, & Pertuzumab for HR+/-, HER2+ BC"

By Insights from 2023 ASCO® Annual Meeting FEATURING Nicholas McAndrew
By Insights from 2023 ASCO® Annual Meeting FEATURING Nicholas McAndrew
297 views
June 29, 2023
1 Comment
Login to view comments. Click here to Login

Featured Video

19:22
Janssen Oncology

Doc Talk Podcast

Feat. J. Hamilton, M. Fabrizio, M. Taha

Featured Video

21:09
Exelixis

Primary Analysis and Follow-up Data of a Combination Therapy in 1L a…

Feat. S. Ratnam
Breast
14:37
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Practical Implications of SONIA Trial Res…

Feat. N. El Saghir
09:50
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Randomised Open-Label Phase II FAIM Study…

Feat. I. Browne
09:52
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Real-World Patient Characteristics & …

Feat. J. Meisel
29:14
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Breast Cancer Surgery - Too Much, Too Lit…

Feat. S. Khan
06:37
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "A Phase 1b Trial Evaluating the Safety of…

Feat. N. McAndrew
04:27
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "BRCA Alterations - Beyond Breast and Ovar…

Feat. T. Yap
04:05
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "evERA Breast Cancer Phase III Study - Gir…

Feat. E. Mayer
06:17
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Results From the Randomized Phase 3 OLIGO…

Feat. A. Van Ommen - Nijhof
09:35
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Primary Outcome Analysis of the Phase 3 S…

Feat. N. Wortelboer
08:51
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Effects of Ovarian Ablation or Suppressio…

Feat. R. Gray
07:47
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "The X-7/7 Randomized Trial - Fixed Dose C…

Feat. C. Bohnenkamp
23:03
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Neoadjuvant Therapy in TNBC - Where We Ar…

Feat. E. Stringer-Reasor
10:02
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Double-Blind, Placebo-Controlled Phase 3 …

Feat. N. Ibrahim
05:36
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Prognostic Impact of Adjuvant Endocrine T…

Feat. Y. Takahashi
08:41
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "10-Year Update of the Short-HER Phase III…

Feat. P. Conte
12:23
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: Role of Endocrine Therapy Timing Intake in Pts …

Feat. S. Giacchetti
07:17
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Primary Results of NCCH1607/PATHWAY, an A…

Feat. T. Kogawa
07:28
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "A Randomized Controlled Trial Comparing P…

Feat. T. Shien
13:15
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Biomarkers Predicting Response to 5 IO Ar…

Feat. D. Wolf
13:20
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "lidERA Breast Cancer Phase III Adjuvant S…

Feat. C. Geyer
10:50
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "MammaPrint Index as a Predictive Biomarke…

Feat. W. Audeh
16:42
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Late Recurrences in ER+ Breast Cancer - W…

Feat. M. Gnant
11:31
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Top 5 Abstracts Summary: "SONIA, NATALEE, PHERGain, …

Feat. P. Tarantino
05:27
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Final Results of the Phase 3 SAFE Trial -…

Feat. C. Becherini, L. Livi
23:58
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Summary: "mBC Expert Panel Discussion on Key Trials …

Feat. H. Rugo, K. Jhaveri
28:36
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Summary: "eBC Expert Panel Discussion on Key Trials …

Feat. H. Rugo, K. Jhaveri
13:35
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Subgroup Analysis of the RIGHT Choice Tri…

Feat. N. El Saghir
06:57
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "ESR1 Mutational Landscape and Impact of C…

Feat. A. Medford
06:55
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Comparative OS of Pts in Trials of CKD4/6…

Feat. C. Kappel
08:00
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Primary Efficacy Analyses of NeoRHEA, Neo…

Feat. M. Ignatiadis
11:13
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Are We Splitting HERs? The Highs and Lows…

Feat. D. Rimm
16:08
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Tailoring Post-Neoadjuvant Therapy in TNB…

Feat. H. Han
08:38
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Utility of Ki67 in Guiding Adjuvant Abema…

Feat. R. Patel
07:47
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "BC Staging for Patients With 'Low-Ri…

Feat. J. Plichta
02:59
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Oral Elacestrant vs. Standard-of-Care in …

Feat. V. Kaklamani
09:32
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "TROPiCS-02 Phase 3 Study Final OS Analysi…

Feat. S. Tolaney
04:28
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "ASCENT-05/OptimICE-RD (AFT-65): Adjuvant …

Feat. S. Tolaney
12:48
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Association of Tumor-Infiltrating Lymphoc…

Feat. M. Tesch
05:21
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Pertuzumab Retreatment in Patients With H…

Feat. Y. Yamamoto